Zacks: Brokerages Expect Addus Homecare Co. (ADUS) to Post $0.53 EPS

Share on StockTwits

Wall Street brokerages expect Addus Homecare Co. (NASDAQ:ADUS) to post earnings per share of $0.53 for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Addus Homecare’s earnings. The highest EPS estimate is $0.59 and the lowest is $0.47. Addus Homecare reported earnings of $0.46 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 15.2%. The firm is scheduled to announce its next quarterly earnings report on Monday, March 4th.

According to Zacks, analysts expect that Addus Homecare will report full year earnings of $1.94 per share for the current year, with EPS estimates ranging from $1.88 to $2.01. For the next year, analysts expect that the company will post earnings of $2.40 per share, with EPS estimates ranging from $2.15 to $2.70. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that follow Addus Homecare.

Addus Homecare (NASDAQ:ADUS) last released its earnings results on Tuesday, November 6th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.40 by $0.08. The company had revenue of $137.63 million during the quarter, compared to analyst estimates of $139.43 million. Addus Homecare had a net margin of 3.25% and a return on equity of 9.55%.

Several research analysts have weighed in on the company. Zacks Investment Research downgraded Addus Homecare from a “hold” rating to a “strong sell” rating in a research note on Monday, August 13th. BidaskClub upgraded Addus Homecare from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 30th. ValuEngine upgraded Addus Homecare from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, September 4th. Finally, Jefferies Financial Group assumed coverage on Addus Homecare in a research note on Tuesday, August 21st. They issued a “buy” rating and a $75.00 price target for the company. Two investment analysts have rated the stock with a hold rating, six have given a buy rating and two have issued a strong buy rating to the company’s stock. Addus Homecare presently has a consensus rating of “Buy” and a consensus price target of $73.50.

Addus Homecare stock traded down $1.73 during midday trading on Friday, hitting $74.40. The stock had a trading volume of 155,230 shares, compared to its average volume of 330,611. Addus Homecare has a 52-week low of $31.67 and a 52-week high of $77.82. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $997.18 million, a price-to-earnings ratio of 51.31, a P/E/G ratio of 3.01 and a beta of -0.27.

In other news, CFO Brian Poff sold 5,000 shares of the stock in a transaction that occurred on Wednesday, November 28th. The stock was sold at an average price of $73.76, for a total transaction of $368,800.00. Following the completion of the transaction, the chief financial officer now directly owns 17,770 shares in the company, valued at approximately $1,310,715.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Eos Capital Partners Iii L. P sold 540,000 shares of the stock in a transaction that occurred on Wednesday, November 28th. The shares were sold at an average price of $72.46, for a total value of $39,128,400.00. The disclosure for this sale can be found here. Insiders sold a total of 923,400 shares of company stock valued at $66,935,850 over the last 90 days. 34.80% of the stock is currently owned by corporate insiders.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of Addus Homecare by 48.5% during the 3rd quarter. Vanguard Group Inc. now owns 544,748 shares of the company’s stock valued at $38,214,000 after acquiring an additional 177,827 shares during the last quarter. Sawgrass Asset Management LLC bought a new position in shares of Addus Homecare during the 3rd quarter valued at approximately $434,000. TIAA CREF Investment Management LLC boosted its position in shares of Addus Homecare by 87.7% during the 3rd quarter. TIAA CREF Investment Management LLC now owns 96,758 shares of the company’s stock valued at $6,788,000 after acquiring an additional 45,214 shares during the last quarter. Teachers Advisors LLC boosted its position in shares of Addus Homecare by 8.2% during the 3rd quarter. Teachers Advisors LLC now owns 17,138 shares of the company’s stock valued at $1,202,000 after acquiring an additional 1,306 shares during the last quarter. Finally, AQR Capital Management LLC boosted its position in shares of Addus Homecare by 348.5% during the 3rd quarter. AQR Capital Management LLC now owns 177,531 shares of the company’s stock valued at $12,454,000 after acquiring an additional 137,945 shares during the last quarter. Hedge funds and other institutional investors own 92.89% of the company’s stock.

Addus Homecare Company Profile

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.

Featured Article: Insider Trading

Get a free copy of the Zacks research report on Addus Homecare (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.